Sage Therapeutics (SAGE) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

SAGE is expected to report earnings to fall 8.24% to -155 cents per share on November 05

Sage Therapeutics SAGE Stock Earnings Reports

Q3'24

Est.

$-1.56

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.15

Q4'23

Beat

by $0.73

Q3'23

Missed

by $0.69

The last earnings report on July 31 showed earnings per share of -170 cents, missing the estimate of -163 cents. With 558.47K shares outstanding, the current market capitalization sits at 457.88M.

View a ticker or compare two or three

Compare

SAGE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SAGE
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for SAGE (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

215 First Street

Phone

+1 617 299-8380

Employees

487

Web

https://www.sagerx.com